Untreated High Blood Pressure Raises Bleeding Stroke Risk
UC Medical Center researchers say about a quarter of highly dangerous bleeding strokes would be prevented if people with high blood pressure would get treatment.
Daniel Woo, MD, and his team studied 549 patients to determine whether those with untreated blood pressure, which is "highly prevalent," face a different risk of bleeding stroke than treated patients.
Although both untreated and treated patients were found to be at significant risk, the researchers determined that blood pressure treatment would have prevented 17 to 28 percent of the bleeding strokes.
Of particular note, African-American were at a higher risk of having untreated hypertension. Yet, in patients who had medical insurance there was no difference in the rate of untreated hypertension. This suggests that access to healthcare is a significant factor in stroke prevention.
Stroke is the third leading cause of death and the leading cause of disability in the U.S. Bleeding occurs in 20 percent of all stroke cases and results in a 40 to 50 percent death rate.
The report appears in the May edition of the American Heart Association journal Stroke.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.